|
🐜
|
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
135 auth.
Anthony G. Marson,
G. Burnside,
Richard Appleton,
Dave Smith,
John Paul Leach,
G. Sills,
C. Tudur-Smith,
C. Plumpton,
D. Hughes,
P. Williamson,
G. Baker,
S. Balabanova,
Claire Taylor,
Richard Brown,
Daniel Hindley,
...
S. Howell,
M. Maguire,
R. Mohanraj,
Philip Smith,
Karen Lanyon,
M. Manford,
M. Chitre,
A. Parker,
N. Swiderska,
Richard Appleton,
J. Pauling,
A. Hughes,
Rajat Gupta,
S. Hanif,
M. Awadh,
S. Ragunathan,
Nicola Cable,
P. Cooper,
Daniel Hindley,
K. Rakshi,
S. Molloy,
M. Reuber,
K. Ayonrinde,
Martin Wilson,
Satyanarayana Saladi,
J. Gibb,
L. Funston,
Damhait Cassidy,
J. Boyd,
Mal Ratnayaka,
Hani Faza,
M. Sadler,
H. Al-Moasseb,
Clare Galtrey,
D. Wren,
A. Olabi,
G. Fuller,
Muhammed Khan,
C. Kallappa,
R. Chinthapalli,
Baba Aji,
R. Davies,
Kathryn Foster,
Nikolas Hitiris,
M. Maguire,
Nahin Hussain,
S. Dowson,
J. Ellison,
B. Sharrack,
Vandna Gandhi,
R. Powell,
P. Tittensor,
Beatrice Summers,
S. Shashikiran,
P. Dison,
S. Samarasekera,
D. Mccorry,
K. White,
K. Nithi,
M. Richardson,
Richard Brown,
R. Page,
D. Deekollu,
S. Slaght,
S. Warriner,
Mansoor Ahmed,
A. Chaudhuri,
G. Chow,
J. Artal,
Danute Kucinskiene,
H. Sreenivasa,
S. Velmurugan,,
C. Zipitis,
B. Mclean,
Vaithianathar Lal,
Angelous Gregoriou,
Paul Maddison,
T. Pickersgill,
Joseph Anderson,
C. Lawthom,
S. Howell,
G. Whitlingum,
W. Rakowicz,
Lucy Kinton,
A. McLellan,
N. Vora,
S. Zuberi,
A. Kelso,
I. Hughes,
J. Martland,
H. Emsley,
C. de Goede,
RP Singh,
Carl-Christian Moor,
J. Aram,
R. Mohanraj,
K. Sakthivel,
Suresh Nelapatla,
C. Rittey,
Ashwin Pinto,
John Paul Leach,
H. Cock,
Anna Richardson,
E. Houston,
Christopher Cooper,
Geoff Lawson,
A. Massarano,
C. Burness,
Anthony G. Marson,
Dave Smith,
U. Wieshmann,
I. Dey,
Puthuval Sivakumar,
Lap-Kong Yeung,
Philip Smith,
H. Bentur,
T. Heafield,
A. Mathew,
Dave Smith,
P. Jauhari
|
6 |
2021 |
6
🐜
|
|
🐜
|
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
135 auth.
A. Marson,
G. Burnside,
R. Appleton,
Dave Smith,
J. Leach,
G. Sills,
C. Tudur-Smith,
C. Plumpton,
D. Hughes,
P. Williamson,
G. Baker,
S. Balabanova,
Claire Taylor,
Richard Brown,
D. Hindley,
...
S. Howell,
M. Maguire,
R. Mohanraj,
PhilipH. Smith,
Karen Lanyon,
M. Manford,
M. Chitre,
A. Parker,
N. Swiderska,
R. Appleton,
J. Pauling,
A. Hughes,
Rajat Gupta,
S. Hanif,
M. Awadh,
S. Ragunathan,
Nicola Cable,
P. Cooper,
D. Hindley,
K. Rakshi,
S. Molloy,
M. Reuber,
K. Ayonrinde,
Martin Wilson,
Satyanarayana Saladi,
J. Gibb,
L. Funston,
Damhait Cassidy,
J. Boyd,
Mal Ratnayaka,
Hani Faza,
M. Sadler,
H. Al-Moasseb,
Clare Galtrey,
D. Wren,
A. Olabi,
G. Fuller,
Muhammed Khan,
C. Kallappa,
R. Chinthapalli,
Baba Aji,
R. Davies,
Kathryn Foster,
Nikolas Hitiris,
M. Maguire,
Nahin Hussain,
S. Dowson,
J. Ellison,
B. Sharrack,
Vandna Gandhi,
R. Powell,
P. Tittensor,
Beatrice Summers,
S. Shashikiran,
P. Dison,
S. Samarasekera,
D. Mccorry,
K. White,
K. Nithi,
M. Richardson,
Richard Brown,
R. Page,
D. Deekollu,
S. Slaght,
S. Warriner,
Mansoor Ahmed,
A. Chaudhuri,
G. Chow,
J. Artal,
Danute Kucinskiene,
H. Sreenivasa,
S. Velmurugan,,
C. Zipitis,
B. Mclean,
Vaithianathar Lal,
Angelous Gregoriou,
Paul Maddison,
T. Pickersgill,
Joseph Anderson,
C. Lawthom,
S. Howell,
G. Whitlingum,
W. Rakowicz,
Lucy Kinton,
A. McLellan,
N. Vora,
S. Zuberi,
A. Kelso,
I. Hughes,
J. Martland,
H. Emsley,
C. de Goede,
RP Singh,
Carl-Christian Moor,
J. Aram,
R. Mohanraj,
K. Sakthivel,
Suresh Nelapatla,
C. Rittey,
Ashwin Pinto,
J. Leach,
H. Cock,
Anna Richardson,
E. Houston,
Christopher Cooper,
Geoff Lawson,
A. Massarano,
C. Burness,
A. Marson,
Dave Smith,
U. Wieshmann,
I. Dey,
Puthuval Sivakumar,
Lap-Kong Yeung,
Philip Smith,
H. Bentur,
T. Heafield,
A. Mathew,
Dave Smith,
P. Jauhari
|
6 |
2021 |
6
🐜
|
|
🐢
|
Anti-epileptic drugs: a guide for the non-neurologist.
Joseph Anderson,
Carl-Christian Moor
|
4 |
2010 |
4
🐢
|
|
🐜
|
Seizure Outcome after surgery for Insula High Grade Glioma.
10 auth.
Joshua Pepper,
Hadleigh Cuthbert,
Teresa Scott,
I. Ughratdar,
V. Wykes,
C. Watts,
...
P. D’Urso,
K. Karabatsou,
Carl-Christian Moor,
E. Albanese
|
2 |
2021 |
2
🐜
|
|
🐢
|
175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data
10 auth.
Pyae Phyo San,
N. Davies,
V. Srinivasan,
Amrit Samra,
S. Paluri,
S. Ubben,
...
Prateek Kumar,
Konstantinos Kiolachidis,
Saikat Dhar,
Carl-Christian Moor
|
0 |
2022 |
0
🐢
|
|
🐢
|
090 Anti-epileptic medications: causes of adherence failure
M. Thaller,
Maxine Maxwell,
Carl-Christian Moor
|
0 |
2019 |
0
🐢
|
